CMS Withdraws Medicaid Cell, Gene Therapy Price ‘Verification’ Survey Plan

 
• By Cathy Kelly
  
The Audit Plan Would Have Exceeded Agency Authority, Critics Said. • Source: Shutterstock

More from Market Access

More from Pink Sheet